צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: TNF Pharmaceuticals (TNFA)

TNF Pharmaceuticals (TNFA) possesses significant pricing power due to its selective drugs for treating autoimmune pathologies, which defines the YoY sales volume growth trajectory over the rolling period, where this metric equals . However, the risk of insufficient clinical evidence compared to the market and the competition for investment amid a strategic shift toward geriatrics create certain financial pressure on the company.
TNF Pharmaceuticals (TNFA) - פילוחי מדדים ודוחות פיננסיים

For a defensive portfolio, fundamental screening requires an analysis of business expansion rates, where this indicator measures the daily change in revenue over the last 12 months relative to the same period last year. The stability of the R&D core at TNF Pharmaceuticals (TNFA) allows the TTM revenue growth trajectory compared to last year to be assessed as a pure vector of asset commercialization, stripped of mass hiring costs.